Tag: Cerezyme

Gaucher disease affects an estimated 1 in 50,000 to 100,000 people in the general population [1.10.4]. For those undergoing enzyme replacement therapy, a primary question is: **how long does a Cerezyme infusion take?** This intravenous treatment typically lasts between one to two hours [1.2.1, 1.2.2].

For the average patient, the annual list price of Cerezyme (imiglucerase) is approximately $200,000, though this figure can vary significantly based on dosage, disease severity, and individual factors. This high cost is typical for specialized orphan drugs designed to treat rare genetic disorders like Gaucher disease.

Over 6,000 patients worldwide are part of the International Collaborative Gaucher Group Gaucher Registry, which has provided long-term data supporting the use of Cerezyme (imiglucerase). This therapy is specifically approved for treating certain types of Gaucher disease and targets the debilitating symptoms associated with the condition. Understanding **what are the indications for Cerezyme** is crucial for patients and healthcare providers managing this rare genetic disorder.

Affecting approximately 1 in 40,000 to 60,000 live births, Gaucher disease is a rare genetic disorder caused by a deficient enzyme called glucocerebrosidase. The **cerezyme treatment** is an enzyme replacement therapy designed to manage the symptoms of this serious condition.